共 122 条
[1]
Al-AttarAl GhonaimFollero BMPM(2021)POS-351 diabetes, the leading cause of end-stage renal disease and characteristics of hemodialysis in KSA Kidney Int Reports 6 S153-1927
[2]
Shurraw S(2011)Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study Arch Intern Med 171 1920-39
[3]
Hemmelgarn B(2002)Glycohaemoglobin measurement: methodological differences in relation to interference by urea Acta Diabetol 39 35-273
[4]
Lin M(2012)Endogenous factors modified by hemodialysis may interfere with the accuracy of blood glucose-measuring device Hemodial Int 16 266-79
[5]
Lee KF(2014)Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study Patient Prefer Adherence 8 237-2263
[6]
Szeto YT(2020)Basics and use of continuous glucose monitoring (CGM) in diabetes therapy J Lab Med 44 71-1094
[7]
Benzie IFF(2016)Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial Lancet (London, England) 388 2254-1669
[8]
Ogawa T(2020)Comparison of interstitial fluid glucose levels obtained by continuous glucose monitoring and flash glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis J Diabetes Sci Technol 14 1088-1656
[9]
Murakawa M(2017)Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes Diabetes Technol Ther 19 S-25-399
[10]
Matsuda A(2021)Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study Ther Apher Dial 25 586-807